DAVIS STEPHEN — SEC Form 4 filings
SEC reporting owner CIK 1131146. 6 Form 4 filings on record with FilingPulse; latest filed 2024-08-20.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-09 to 2024-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 96,771 shares, $1,720,021 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 31,747 shares @ $15.28 ($485,094) in ACADIA PHARMACEUTICALS INC, filed 2024-08-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | CEO, Director | 6 | — | 7 legs · 96,771 sh · $1,720,021 | 14 |
Form 4 filings — DAVIS STEPHEN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-20 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 17,333 @ $0 · Grant/award (A): 44,782 @ $0 · Sale (S): 31,747 @ $15.28 | EDGAR |
| 2024-05-03 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 22,391 · Sale (S): 11,427 @ $16.94 · Option exercise (M): 22,391 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 17,333 · Option exercise (M): 34,666 · Sale (S): 8,858 @ $17.87 · Sale (S): 17,716 @ $17.87 · Option exercise (M): 17,333 (derivative) @ $0 · Option exercise (M): 34,666 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 34,666 @ $0 · Sale (S): 17,714 @ $17.90 · Grant/award (A): 286,451 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 10,946 · Sale (S): 5,577 @ $24.67 · Option exercise (M): 10,946 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 9,528 · Sale (S): 3,732 @ $29.96 · Option exercise (M): 9,528 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1131146 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →